UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000001220
Receipt No. R000001462
Scientific Title Phase II study of rituximab containing induction chemotherapy (R-high-CHOP followed by CHASER) and high-dose chemotherapy (LEED) supported with auto-PBSCT for previously untreated patients with advanced mantle cell lymphoma(JCOG0406)
Date of disclosure of the study information 2008/06/30
Last modified on 2013/03/26 17:53:16

No. Disposal Last modified on Item of update
1 Insert 2008/06/30 10:01:23
2 Update 2009/08/11 16:07:18 Name of person sending information
Name of person sending information
Division name
Division name
3 Update 2010/01/22 11:07:21 Recruitment status
4 Update 2010/01/22 11:07:51 Institutions
5 Update 2010/09/02 11:38:22 Organization
6 Update 2011/08/03 13:16:05 Last name of lead principal investigator
Last name of contact person
Name of person sending information
Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2012/05/07 18:40:23 Institutions
8 Update 2012/06/20 11:47:01 Acronym
9 Update 2013/03/26 17:53:16 Recruitment status

Contact us.